249 related articles for article (PubMed ID: 23344621)
1. Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells.
Novobrantseva TI; Borodovsky A; Wong J; Klebanov B; Zafari M; Yucius K; Querbes W; Ge P; Ruda VM; Milstein S; Speciner L; Duncan R; Barros S; Basha G; Cullis P; Akinc A; Donahoe JS; Narayanannair Jayaprakash K; Jayaraman M; Bogorad RL; Love K; Whitehead K; Levins C; Manoharan M; Swirski FK; Weissleder R; Langer R; Anderson DG; de Fougerolles A; Nahrendorf M; Koteliansky V
Mol Ther Nucleic Acids; 2012 Jan; 1(1):e4. PubMed ID: 23344621
[TBL] [Abstract][Full Text] [Related]
2. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
[TBL] [Abstract][Full Text] [Related]
3. Lipidoid-polymer hybrid nanoparticles loaded with TNF siRNA suppress inflammation after intra-articular administration in a murine experimental arthritis model.
Jansen MAA; Klausen LH; Thanki K; Lyngsø J; Skov Pedersen J; Franzyk H; Nielsen HM; van Eden W; Dong M; Broere F; Foged C; Zeng X
Eur J Pharm Biopharm; 2019 Sep; 142():38-48. PubMed ID: 31199978
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.
Jyotsana N; Sharma A; Chaturvedi A; Budida R; Scherr M; Kuchenbauer F; Lindner R; Noyan F; Sühs KW; Stangel M; Grote-Koska D; Brand K; Vornlocher HP; Eder M; Thol F; Ganser A; Humphries RK; Ramsay E; Cullis P; Heuser M
Ann Hematol; 2019 Aug; 98(8):1905-1918. PubMed ID: 31104089
[TBL] [Abstract][Full Text] [Related]
5. Optimizing the Intracellular Delivery of Therapeutic Anti-inflammatory TNF-α siRNA to Activated Macrophages Using Lipidoid-Polymer Hybrid Nanoparticles.
Lokras A; Thakur A; Wadhwa A; Thanki K; Franzyk H; Foged C
Front Bioeng Biotechnol; 2020; 8():601155. PubMed ID: 33520957
[TBL] [Abstract][Full Text] [Related]
6. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
7. Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia.
Connerty P; Moles E; de Bock CE; Jayatilleke N; Smith JL; Meshinchi S; Mayoh C; Kavallaris M; Lock RB
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683974
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated gene silencing in non-human primates.
Zimmermann TS; Lee AC; Akinc A; Bramlage B; Bumcrot D; Fedoruk MN; Harborth J; Heyes JA; Jeffs LB; John M; Judge AD; Lam K; McClintock K; Nechev LV; Palmer LR; Racie T; Röhl I; Seiffert S; Shanmugam S; Sood V; Soutschek J; Toudjarska I; Wheat AJ; Yaworski E; Zedalis W; Koteliansky V; Manoharan M; Vornlocher HP; MacLachlan I
Nature; 2006 May; 441(7089):111-4. PubMed ID: 16565705
[TBL] [Abstract][Full Text] [Related]
9. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable lipid nanoparticles induce a prolonged RNA interference-mediated protein knockdown and show rapid hepatic clearance in mice and nonhuman primates.
Suzuki Y; Hyodo K; Suzuki T; Tanaka Y; Kikuchi H; Ishihara H
Int J Pharm; 2017 Mar; 519(1-2):34-43. PubMed ID: 28089936
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticles for short interfering RNA delivery.
Leung AK; Tam YY; Cullis PR
Adv Genet; 2014; 88():71-110. PubMed ID: 25409604
[TBL] [Abstract][Full Text] [Related]
12. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
[TBL] [Abstract][Full Text] [Related]
13. A novel therapeutic strategy for cartilage diseases based on lipid nanoparticle-RNAi delivery system.
Wang S; Wei X; Sun X; Chen C; Zhou J; Zhang G; Wu H; Guo B; Wei L
Int J Nanomedicine; 2018; 13():617-631. PubMed ID: 29440889
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
15. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
[TBL] [Abstract][Full Text] [Related]
16. Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.
Thi EP; Mire CE; Ursic-Bedoya R; Geisbert JB; Lee ACH; Agans KN; Robbins M; Deer DJ; Fenton KA; MacLachlan I; Geisbert TW
Sci Transl Med; 2014 Aug; 6(250):250ra116. PubMed ID: 25143366
[TBL] [Abstract][Full Text] [Related]
17. Silencing TNFα with lipidoid nanoparticles downregulates both TNFα and MCP-1 in an in vitro co-culture model of diabetic foot ulcers.
Kasiewicz LN; Whitehead KA
Acta Biomater; 2016 Mar; 32():120-128. PubMed ID: 26689461
[TBL] [Abstract][Full Text] [Related]
18. Arthritic joint-targeting small interfering RNA-encapsulated liposome: implication for treatment strategy for rheumatoid arthritis.
Komano Y; Yagi N; Onoue I; Kaneko K; Miyasaka N; Nanki T
J Pharmacol Exp Ther; 2012 Jan; 340(1):109-13. PubMed ID: 21994423
[TBL] [Abstract][Full Text] [Related]
19. Cytosolic phospholipase A2α gene silencing in the myeloid lineage alters development of Th1 responses and reduces disease severity in collagen-induced arthritis.
Courties G; Baron M; Presumey J; Escriou V; van Lent P; Scherman D; Cantagrel A; van den Berg WB; Jorgensen C; Apparailly F; Davignon JL
Arthritis Rheum; 2011 Mar; 63(3):681-90. PubMed ID: 21360497
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated virus type 5-mediated intraarticular administration of tumor necrosis factor small interfering RNA improves collagen-induced arthritis.
Khoury M; Courties G; Fabre S; Bouffi C; Seemayer CA; Vervoordeldonk MJ; Tak PP; Jorgensen C; Apparailly F
Arthritis Rheum; 2010 Mar; 62(3):765-70. PubMed ID: 20187132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
